Showing results (411-420 of 1,188) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|December 6, 2011
Subgroup analyses of clinical effectiveness to support health technology assessmentsMarie-Ange Paget, Christy Chuang-Stein, Christine Fletcher, et al.Pharmaceutical Statistics|May 9, 2012
Imputation of missing variance data using non-linear mixed effects modelling to enable an inverse variance weighted meta-analysis of summary-level longitudinal data: a case studyMartin BoucherPharmaceutical Statistics|February 14, 2012
Sample size re-estimation for survival data in clinical trials with an adaptive designKanae Togo, Manabu IwasakiPharmaceutical Statistics|February 17, 2012
Blinded assessment of treatment effects for survival endpoint in an ongoing trialJun Xie, Hui Quan, Ji ZhangPharmaceutical Statistics|February 11, 2012
Asymptotic properties of mean survival estimate based on the Kaplan-Meier curve with an extrapolated tailQi Gong, Liang FangPharmaceutical Statistics|February 21, 2012
One-sample and two-sample analysis of heterogeneous person-time data in clinical trialsJing Xu, Michael LaValleyPharmaceutical Statistics|January 11, 2012
Operating characteristics of a Simon two-stage phase II clinical trial design incorporating continuous toxicity monitoringH E Ray, S N RaiPharmaceutical Statistics|January 11, 2012
Admissible two-stage designs for phase II cancer clinical trials that incorporate the expected sample size under the alternative hypothesisAdrian P Mander, James M S Wason, Michael J Sweeting, et al.Pharmaceutical Statistics|September 20, 2011
Designing a non-inferiority study in kidney transplantation: a case studySteffen Witte, Heinz Schmidli, Anthony O'Hagan, et al.Pharmaceutical Statistics|October 15, 2011
Statistical aspects in comparative benefit-risk assessment: challenges and opportunities for pharmaceutical statisticiansGeorge Quartey, Jixian WangPageof 119